GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
4.120
-0.170 (-3.96%)
At close: Apr 4, 2025, 4:00 PM
4.121
+0.001 (0.03%)
After-hours: Apr 4, 2025, 7:56 PM EDT
GoodRx Holdings Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for GoodRx Holdings stock have an average target of 8.68, with a low estimate of 6.00 and a high estimate of 16. The average target predicts an increase of 110.68% from the current stock price of 4.12.
Analyst Consensus: Buy
* Price targets were last updated on Feb 28, 2025.
Analyst Ratings
The average analyst rating for GoodRx Holdings stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 9 | 9 | 9 | 9 | 8 | 6 |
| Hold | 6 | 5 | 4 | 4 | 4 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 16 | 15 | 15 | 14 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $9 → $8 | Buy | Maintains | $9 → $8 | +94.17% | Feb 28, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $7 → $6.25 | Strong Buy | Maintains | $7 → $6.25 | +51.70% | Jan 10, 2025 |
| Keybanc | Keybanc | Buy Maintains $7 → $6 | Buy | Maintains | $7 → $6 | +45.63% | Jan 8, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $7 → $6 | Hold | Maintains | $7 → $6 | +45.63% | Dec 17, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $10 → $7 | Strong Buy | Maintains | $10 → $7 | +69.90% | Nov 13, 2024 |
Financial Forecast
Revenue This Year
840.95M
from 792.32M
Increased by 6.14%
Revenue Next Year
896.30M
from 840.95M
Increased by 6.58%
EPS This Year
0.41
from 0.04
Increased by 914.90%
EPS Next Year
0.48
from 0.41
Increased by 17.34%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 878.1M | 958.3M | 1.1B | ||
| Avg | 841.0M | 896.3M | 961.8M | ||
| Low | 796.3M | 830.6M | 864.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.8% | 14.0% | 17.3% | ||
| Avg | 6.1% | 6.6% | 7.3% | ||
| Low | 0.5% | -1.2% | -3.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.47 | 0.53 | 0.66 | ||
| Avg | 0.41 | 0.48 | 0.54 | ||
| Low | 0.34 | 0.38 | 0.47 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1,081.3% | 29.3% | 38.9% | ||
| Avg | 914.9% | 17.3% | 13.7% | ||
| Low | 757.5% | -5.9% | -1.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.